StonvexLoading…
StonvexStonvexStonvexCore line items from BGMS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $778.00K | $747.00K | $81.00K | $43.00K |
Operating Income | $-246.00K | $-8.43M | $-7.34M | $-12.00M |
Net Income | $-197.00K | $-3.00M | $-2.39M | $-11.21M |
EPS (Diluted) | $-0.04 | $-6.45 | $-2.86 | $-502.46 |
Total Assets | $7.56M | $8.19M | $8.16M | $4.09M |
Total Liabilities | $804.00K | $1.34M | $1.06M | $6.27M |
Cash & Equivalents | $3.34M | $3.50M | $3.84M | $3.14M |
Free Cash Flow OCF − CapEx | $-279.00K | Not available | Not available | Not available |
Shares Outstanding | 5.52M | 5.40M | 3.50M | 36.91K |